Monday, March 3rd, 2008
Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced that it has recently entered into an agreement with Medical Miracles (Leeds, UK) to broker its patented and CE Marked chronic total occlusion (CTO) device, POLAR™.
POLAR™ (Path Of Least Arterial Resistance) is a mechanical device that generates reciprocal ...
Posted in Medical Devices | No Comments »
Monday, February 25th, 2008
Ipsen (Paris:IPN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) provided a positive opinion for Adenuric® (febuxostat) 80 mg and 120 mg tablets for the treatment of chronic hyperuricaemia in gout and recommended it for marketing authorisation. The CHMP recommendation will ...
Posted in Gout | No Comments »
Wednesday, February 20th, 2008
UCB and sanofi-aventis announced that the U.S. Food and Drug Administration (FDA) approved a New Drug Application (NDA) for XYZAL® (levocetirizine dihydrochloride) 0.5 mg/mL oral solution, a prescription antihistamine indicated for the relief of symptoms associated with indoor and outdoor allergies, as well as the treatment of chronic idiopathic urticaria. ...
Posted in Allergy | No Comments »
Monday, February 18th, 2008
Diamyd Medical (NASDAQ:DMYDY)(STO:DIAMB) announced that it has received approval from the U.S. FDA to initiate a Phase I study in chronic pain using NP2, the company's first drug candidate in its Nerve Targeting Drug Delivery System (NTDDS) gene therapy platform.
NP2, developed by the company's U.S. subsidiary, Diamyd, Inc., in Pittsburgh, ...
Posted in Pain / Anesthetics | No Comments »
Monday, February 18th, 2008
Measures to prevent chronic health conditions among Australia's older workers may be essential to increasing future labour force participation, according to a study in the latest Medical Journal of Australia.
Dr Deborah Schofield and her co-authors from the Northern Rivers University Department of Rural Health looked at which industries and occupational ...
Posted in General | No Comments »
